Cantor Fitzgerald Initiates Coverage On Entera Bio with Overweight Rating

Benzinga Newsdesk www.benzinga.com Positive 53.9%

Neg 0% Neu 0% Pos 53.9%

Cantor Fitzgerald analyst Imogen Mansfield initiates coverage on Entera Bio (NASDAQ:ENTX) with a Overweight rating.

Comments

No comments yet. Be the first!